Journals By Industry - Gene Based Drugs

CAMBRIDGE, Mass. -- Constellation Pharmaceuticals, Inc., today announced that it has entered into a major strategic agreement with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), to launch a...

-Results support elesclomol results seen in human clinical trials- -Elesclomol clinical trials on-going in acute myeloid leukemia and ovarian cancer- LEXINGTON, Mass. -- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) - A report published in...

New Genome Biology publication validates potential for cost-effective clinical sequencing with integrated RainDance and Illumina MiSeq[TM] workflow LEXINGTON, Mass. -- RainDance Technologies, Inc., the Digital Biology[TM] Company, today announced the publication of data...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/8e63db/drug_discovery_and) has announced the addition of the "Drug Discovery and Preclinical Molecules by Therapy Area - Innovation Focuses on Stem Cell Therapies and Gene Therapies" report to their...

License is for Hematopoietic and Solid Tumor Cancers SAVANNAH, Ga. -- Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics leader in the use of patent protected advanced mathematical techniques for personalized medicine, has...

REDWOOD CITY, Calif. -- OncoMed Pharmaceuticals, Inc., a privately held, clinical-stage company developing novel therapeutics that target cancer stem cells, today announced the promotion of Jakob Dupont, M.D., formerly Vice President, Clinical Research,...

NEW YORK -- Rodman & Renshaw, LLC, a wholly owned subsidiary of Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM) announced that it has acted as a Co-Manager to its client Vical Incorporated...

- RNAi Therapeutic Achieves Robust Silencing of PCKS9 and Reductions of Over 50% in LDL Cholesterol, a Validated Clinical Endpoint - - Results Highlight Major Potency Improvements of Second-Generation Lipid Nanoparticle Platform in...

-- Biogen Idec has Option to Develop and Commercialize Promising Compound for Most Common Genetic Cause of Infant Mortality -- -- Biogen Idec's Expertise in Neurology to Aid in Rapid Development of ISIS-SMN...

NIAID-funded Study Designed to Establish the Optimal Dose of Vesicular Stomatitis Virus-Vectored Prophylactic HIV Vaccine in Normal Healthy Adults BALTIMORE -- Profectus BioSciences, Inc., a leader in the development of therapeutic and preventive...

SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), an emerging international biotechnology provider of cell and gene therapy solutions, including encapsulation of live cells and services through their associate SG Austria, released additional information...

ACQUISITIONS Fisher Unitech Inc., Troy, a SolidWorks reseller, purchased the SolidWorks business unit of R&D Technologies, a reseller with offices in Rhode Island and Connecticut. Rockbridge Growth Equity LLC, Detroit, a private equity...

The State of Lower Saxony in Germany has launched a program that it calls the Voluntary Scientific Year, in which high school graduates are introduced to scientific research work in various advanced settings....

Introduction The probability of acquiring an infection in a healthcare setting is relatively high, and the risk of death is not negligible. Data from the Centers for Disease Control and Prevention (CDC) and...

The mapping of the human genome is helping to usher in a more personalized approach to medical intervention. Knowledge of an individual's genomic makeup can help predict if that person might be predisposed...

Eli Lilly's board of directors has elected Katherine Baicker, Ph.D. as a new member. Baicker is Professor of Health Economics in the Department of Health Policy and Management at the Harvard School of...

Company Profiles Leading Local Companies Strengths The world's largest drugmakers in terms of revenue. A focus on R&D to drive growth. Weaknesses Loss of patent protection for Lipitor (atorvastatin) in the US during...

Gene mutation is far more common and more natural than some people may think. Although we tend to think of ourselves as genetically stable entities, the truth is that every one of us...

* It's a weekday morning at the University of Central Florida, inside a building that's part of the Institute for Simulation & Training. A puppeteer - clad in a black bodysuit outfitted with...